about
Structure of the MLL CXXC domain-DNA complex and its functional role in MLL-AF9 leukemia.Epigenetics in Cancer: A Hematological PerspectiveNUP98 dysregulation in myeloid leukemogenesisMisguided transcriptional elongation causes mixed lineage leukemiaBioassays to monitor Taspase1 function for the identification of pharmacogenetic inhibitorsMixed lineage leukemia-septin 5 fusion transcript in de novo adult acute myeloid leukemia with t(11;22)(q23;q11.2): A case reportHomozygous inv(11)(q21q23) and MLL gene rearrangement in two patients with myeloid neoplasmsDevelopment of five dual-color, double-fusion fluorescence in situ hybridization assays for the detection of common MLL translocation partnersThe MLL recombinome of acute leukemias in 2013.Development of a high-throughput screening-compatible assay for the discovery of inhibitors of the AF4-AF9 interaction using AlphaScreen technologyChallenges and opportunities in targeting the menin-MLL interaction.Rapid high-resolution mapping of balanced chromosomal rearrangements on tiling CGH arrays.A novel zinc finger gene, ZNF465, is inappropriately expressed in acute myeloid leukaemia cells.C/EBPbeta suppression by interruption of CUGBP1 resulting from a complex rearrangement of MLL.Targeting DOT1L and HOX gene expression in MLL-rearranged leukemia and beyondA human ESC model for MLL-AF4 leukemic fusion gene reveals an impaired early hematopoietic-endothelial specification.Molecular genetics of B-precursor acute lymphoblastic leukemiaChallenges and strategies for generating therapeutic patient-specific hemangioblasts and hematopoietic stem cells from human pluripotent stem cellsProspective tracing of MLL-FRYL clone with low MEIS1 expression from emergence during neuroblastoma treatment to diagnosis of myelodysplastic syndromeThe MLL partial tandem duplication in acute myeloid leukaemia.Acute myeloid leukaemia of donor cell origin developing 17 years after allogenic hematopoietic cell transplantation for acute promyelocytic leukaemiaAcute leukemia in early childhood.Cancer genetics of epigenetic genes.Targeted drug discovery for pediatric leukemia.Menin, histone h3 methyltransferases, and regulation of cell proliferation: current knowledge and perspective.Translocations in epithelial cancers.Conquering the complex world of human septins: implications for health and disease.An MLL-SEPT9 fusion and t(11;17)(q23;q25) associated with de novo myelodysplastic syndrome.Molecular pathology of mixed-lineage leukemia.MLL-SEPTIN gene fusions in hematological malignancies.Acute lymphoblastic leukemia and developmental biology: a crucial interrelationshipPathogenetic, Clinical, and Prognostic Features of Adult t(4;11)(q21;q23)/MLL-AF4 Positive B-Cell Acute Lymphoblastic Leukemia.Epigenetics and blood disorders.MLL-SEPT5 fusion transcript in infant acute myeloid leukemia with t(11;22)(q23;q11).RUNX1 meets MLL: epigenetic regulation of hematopoiesis by two leukemia genes.Molecular diagnosis of soft tissue neoplasia: clinical applications and recent advances.The MLL recombinome of acute leukemias in 2017.Hematopoietic stem cell transplantation for pediatric mature B-cell acute lymphoblastic leukemia with non-L3 morphology and MLL-AF9 gene fusion: three case reports and review of the literature.Estradiol induces gene proximity and MLL-MLLT3 fusion in an activation-induced cytidine deaminase-mediated pathway.Targeting human SET1/MLL family of proteins.
P2860
Q27658663-7958E371-DB4E-4606-9C89-50B1BEF7DD99Q28077082-833D6917-8EEE-4410-B8A2-FE9D7CAC1A98Q28298423-1C8D1784-FA3D-4AEA-BA61-52BBF42B7DE0Q28471927-DF2EB171-2BC7-404F-867A-C656FED96DACQ28478269-74339DF5-5A94-4A5B-8C6E-7BDEEDE6A83EQ33727691-6E2F8E5C-6862-4921-9C21-7E034B25EDA4Q33898504-FA139799-3F9B-41F4-ABBC-0DA2B0157DF1Q34620470-E741FA8B-1180-4B23-A856-F88B60CCD030Q34651113-29931177-A1A0-43C2-AB50-D72D9D6BEBC9Q34726135-E9EB4C55-C9ED-48D2-969B-04F2D06A7CC7Q35122366-18532F14-9245-4167-87E5-E781FB71DCB5Q35356418-2ECA1EF4-DFD3-4C6A-B3BB-6E42D8317778Q35565945-9602A070-460C-4D4B-9256-E62E6393B9C0Q35850329-0D89D9BA-2534-4ADF-AA57-48B3A917E4D7Q35967446-F7329F7D-6043-406A-BD11-43BA2D5A6525Q36009252-765654F2-D729-494B-951A-A6C9AE5D2455Q36290242-8CD452EC-BA7F-4B69-AD1D-B25EFEF6EC09Q36436582-65CEA3AD-3C7D-45DC-B6E4-A3B662766261Q36508959-8030C026-E48E-4AFF-9CC4-56BCBA4F1505Q36590734-B01AF58C-3277-46A2-AD56-F4AA85E42DE8Q36736745-C98545DA-EBBC-4322-925F-BB5163728D73Q36854329-7D5112BF-EA93-4B31-9313-0CE3296E8109Q36871595-4F137F8F-968E-47D8-94E6-27B765E58ACBQ36989223-A063CA6F-B5D5-42A9-A27F-845B63E81264Q37347306-0A30C95B-48D7-4689-BD88-5069E688C11EQ37363960-4CC6BC17-A907-478A-BAD1-6AE2CA348164Q37381849-4B54D22E-D583-40A8-92A1-8DF5C67ADB43Q37401608-8BD47241-FB0A-4B74-BDB5-4BCBB9988099Q37620396-D0C62FF7-04AF-4090-A791-C6B9EA81814DQ37895709-569BCB25-AAB1-435A-A913-F4697560AFBBQ37949892-9CCB03AE-0461-4414-8349-F5ED2A836DC9Q37970679-99E6D5EA-824B-469F-8E90-A2D03515BD6CQ38019955-40A7308F-D951-4175-9B15-23F5D9B41606Q38110943-4EE7D867-8981-4A12-8F9D-841435E5461EQ38118553-034DB9D4-E275-49D9-B9FD-C8B43B8F5D7BQ38238574-AD5FC32A-3BA5-4A65-98BC-D80315961115Q38681972-0E4A495B-7B67-4C0A-9EF9-FEE942D9923BQ38809614-D2D5B28F-4058-464D-BC59-4DFA4FBC4BFCQ38965235-CB4DFBE4-58D4-4DE5-BC22-6FA5D251735EQ38979643-C4A03F3B-D869-4626-B4FD-F84F24D8CBF6
P2860
description
im Mai 2006 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 01 May 2006
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в березні 2006
@uk
name
The MLL recombinome of acute leukemias
@en
The MLL recombinome of acute leukemias
@nl
type
label
The MLL recombinome of acute leukemias
@en
The MLL recombinome of acute leukemias
@nl
prefLabel
The MLL recombinome of acute leukemias
@en
The MLL recombinome of acute leukemias
@nl
P2093
P2860
P50
P356
P1433
P1476
The MLL recombinome of acute leukemias
@en
P2093
A Attarbaschi
B Schneider
E Macintyre
F Griesinger
F K Niggli
P2860
P2888
P304
P356
10.1038/SJ.LEU.2404150
P50
P577
2006-05-01T00:00:00Z